Impact of borderline (BL) pulmonary hypertension (PH) in chronic lung diseases (CLD).

L. Piccari On Behalf Of The Rehar Registry (Barcelona, Spain), P. Vitulo (Palermo, Italy), S. Wort (London, United Kingdom), F. Meloni (Pavia, Italy), A. Bertani (Palermo, Italy), I. Blanco (Barcelona, Spain), L. Price (London, United Kingdom), E. Salvaterra (Pavia, Italy), M. Beretta (Palermo, Italy), V. Pérez Rodríguez (Madrid, Spain), C. Mc Cabe (London, United Kingdom), E. Cattaneo (Pavia, Italy), A. Callari (Palermo, Italy), M. López Meseguer (Barcelona, Spain), L. Scelsi (Pavia, Italy), D. Rodríguez (Barcelona, Spain), J. Barberà (Barcelona, Spain), L. Martino (Palermo, Italy), F. Tuzzolino (Palermo, Italy)

Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases
Session: Pulmonary hypertension in lung diseases
Session type: E-poster session
Number: 293
Disease area: Pulmonary vascular diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Piccari On Behalf Of The Rehar Registry (Barcelona, Spain), P. Vitulo (Palermo, Italy), S. Wort (London, United Kingdom), F. Meloni (Pavia, Italy), A. Bertani (Palermo, Italy), I. Blanco (Barcelona, Spain), L. Price (London, United Kingdom), E. Salvaterra (Pavia, Italy), M. Beretta (Palermo, Italy), V. Pérez Rodríguez (Madrid, Spain), C. Mc Cabe (London, United Kingdom), E. Cattaneo (Pavia, Italy), A. Callari (Palermo, Italy), M. López Meseguer (Barcelona, Spain), L. Scelsi (Pavia, Italy), D. Rodríguez (Barcelona, Spain), J. Barberà (Barcelona, Spain), L. Martino (Palermo, Italy), F. Tuzzolino (Palermo, Italy). Impact of borderline (BL) pulmonary hypertension (PH) in chronic lung diseases (CLD).. 293

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: